Clinical Trial of Preoperative Chemotherapy, Intraoperative Radiotherapy, and Esophagectomy for Lower Esophageal Carcinoma
The most clinically important mode of recurrence after operation for patients with esophageal cancer is paratracheal lymph node metastasis. On the other hand, abdominal lymph node metastasis after the operation is also commonly recognized in patients, especially those with lower esophageal cancer. Patients with recurrent abdominal lymph node metastasis complain of abdominal pain, anorexia, or other generalized symptom, and will be able to take nothing per os soon after the operation. To avoid abdominal lymph node metastasis after operation, we have been treating patients with advanced lower esophageal cancer with combined preoperative chemotherapy, intraoperative radiotherapy (IOR) and esophagectomy.
KeywordsEsophageal Cancer Superior Mesenteric Artery Radiation Field Metastatic Lymph Node Esophageal Carcinoma
Unable to display preview. Download preview PDF.
- 1.Ogata M, Tamura Y, Kawamura A, Hikita T, Maeda T, Ogawa Y, Inomata Y, Hirakawa K, Takeda A, Tatibana Y (1984) Intraoperative radiation therapy of esophageal cancer. J Clin Surg 39: 369–375Google Scholar
- 2.Ozawa Y, Kizumi H, Minamide J, Tokunaga M, Fukano F, Osaka Y, Kitamura T, Yamashita K, Shibata T, Hayakawa J (1992) Results of intraoperative radiation therapy for upper mediastinal dissection of esophageal carcinoma. Jpn J Cancer Clin 38: 11–15Google Scholar
- 3.Pack G, Livingston E (1940) Palliative irradiation of gastric cancer. In: Pack G, Livingston E (eds) Treatment of cancer and allied disease, vol 2. Paul B. Hoeber, New York, pp 1088–1109Google Scholar
- 4.Henschke U, Henschke G (1944) Zur Technik der Operationsbestraphlung. Strahlentherapie 74: 228Google Scholar